Skip to main content
SpringerLink
Log in

JOURNAL CLUB

  • JOURNAL CLUB
  • Published:
Medizinische Klinik Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Palumbo A, Brighen S, Caravita T, et al. Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and predisone in elderly patients with multiple myeloma: a randomized trial. Lancet 2006;367:825–31.

    Article  PubMed  CAS  Google Scholar 

  2. Facon T, Mary J., Hulin C, et al. Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomized trial. Lancet 2007;370:1209–18.

    Article  PubMed  CAS  Google Scholar 

  3. Ludwig H, Hajek R, Tothova E, et al. Thalidomide-dexamethasone compared with melphalan-prednisone in elderly patients with multiple myeloma. Blood 2009;113:3435–42.

    Article  PubMed  CAS  Google Scholar 

  4. Rajkumar S, Jacobus S, Callander N, et al. A randomized trial of lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone in newly diagnosed multiple myeloma. J Clin Oncol 2008;26:8504a.abstract.

    Article  Google Scholar 

  5. Facon T, Mary J, Pegourie B. Dexamethasone based regimens versus melphalane-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy. Blood 2006;107:1292–8.

    Article  PubMed  CAS  Google Scholar 

References

  1. DeMatteo RP, Ballman KV, Antonescu CR, et al. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet 2009;373:1097–104.

    Article  PubMed  CAS  Google Scholar 

  2. Singer S, Rubin BP, Lux ML, et al. Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors. J Clin Oncol 2002;20:3898–905.

    Article  PubMed  CAS  Google Scholar 

References

  1. Ashworth A. A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair. J Clin Oncol 2008;26:3785–90.

    Article  PubMed  CAS  Google Scholar 

  2. Fong PC, Boss DS, Yap TA, et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 2009;361:123–34.

    Article  PubMed  CAS  Google Scholar 

  3. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228–47.

    Article  PubMed  CAS  Google Scholar 

  4. Iglehart JD, Silver DF. Synthetic lethality — a new direction in cancer drug development. N Engl J Med 2009;361:189–91.

    Article  PubMed  CAS  Google Scholar 

  5. Audeh MW, Penson RT, Friedlander M, et al. Phase II trial of the oral PARP inhibitor olaparib (AZD2281) in BRCA-deficient advanced ovarian cancer. J Clin Oncol 2009;27:Suppl 18:277s.A5500.

    Google Scholar 

  6. Tutt A, Robson M, Garber JE, et al. Phase II trial of the oral PARP inhibitor olaparib in BRCA-deficient advanced breast cancer. J Clin Oncol 2009;27:Suppl 18:803s.CRA501.

    Google Scholar 

  7. O’shaughnessy J, Osborne C, Pipen J, et al. Efficacy of BSI-201, a poly(ADP) polymerase-1 inhibitor in combination with gemcitabine/carboplatin in patients with metastatic triple-negative breast cancer: results of a randomised phase II trial. J Clin Oncol 2009;27:Suppl 18:793s.A3.

    Google Scholar 

References

  1. Shaheen N, Sharma P, Overholt B, et al. Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med 2009;360:2277–88.

    Article  PubMed  CAS  Google Scholar 

References

  1. Pohl J, Lotterer E, Balzer C, et al. Computed virtual chromoendoscopy versus standard colonoscopy with targeted indigocarmine chromoscopy: a randomized multicentre trial. Gut 2009;58:73–8.

    Article  PubMed  CAS  Google Scholar 

  2. Adler A, Aschenbeck J, Yenerim T, et al. Narrow-band versus white-light high definition television endoscopic imaging for screening colonoscopy: a prospective randomized trial. Gastroenterology 2009;58:73–8.

    Google Scholar 

References

  1. Miehlke S, Madisch A, Karimi D, et al. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study. Gastroenterology 2009;136:2092–100.

    Article  PubMed  CAS  Google Scholar 

References

  1. Ibrahim HN, Foley R, Tan L, et al. Long-term consequences of kidney donation. N Engl J Med 2009;360:459–69.

    Article  PubMed  CAS  Google Scholar 

References

  1. Juurlink DN, Gomes T, Ko DT, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ 2009;180:713–8.

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

JOURNAL CLUB. Med Klin 104, 649–659 (2009). https://doi.org/10.1007/s00063-009-1137-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00063-009-1137-0

Search

Navigation